These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 29587298

  • 1. The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.
    Xu W, Song F, Wang B, Li K, Tian M, Yu M, Pan X, Shi B, Liu J, Gu J, Li Z, Jiang H.
    Cell Physiol Biochem; 2018; 46(1):226-237. PubMed ID: 29587298
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.
    Jiang H, Wang H, Tan Z, Hu S, Wang H, Shi B, Yang L, Li P, Gu J, Wang H, Li Z.
    J Biol Chem; 2011 Feb 18; 286(7):5913-20. PubMed ID: 21163950
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T, Hosui A, Ishida H, Tatsumi T, Kanto T, Hiramatsu N, Fujita N, Yoshimori T, Hayashi N.
    Int J Cancer; 2012 Aug 01; 131(3):548-57. PubMed ID: 21858812
    [Abstract] [Full Text] [Related]

  • 6. The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
    Chen S, Wu DD, Sang XB, Wang LL, Zong ZH, Sun KX, Liu BL, Zhao Y.
    Cell Death Dis; 2017 Oct 12; 8(10):e3118. PubMed ID: 29022892
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12.
    Xu W, Bi Y, Zhang J, Kong J, Jiang H, Tian M, Li K, Wang B, Chen C, Song F, Pan X, Shi B, Kong X, Gu J, Cai X, Li Z.
    Oncotarget; 2015 Nov 17; 6(36):38840-53. PubMed ID: 26474285
    [Abstract] [Full Text] [Related]

  • 9. Intracellular alpha-fetoprotein interferes with all-trans retinoic acid induced ATG7 expression and autophagy in hepatocellular carcinoma cells.
    Wang S, Feng R, Shi Y, Chen D, Weng H, Ding H, Zhang C.
    Sci Rep; 2021 Jan 25; 11(1):2146. PubMed ID: 33495541
    [Abstract] [Full Text] [Related]

  • 10. A monoclonal antibody targeted against epidermal growth factor receptor variant III enhances cisplatin efficiency.
    Li N, Chu Y, Yao L, Ying X, Jiang H, Zhou M, Xu C.
    J Cancer Res Clin Oncol; 2011 Oct 25; 137(10):1455-61. PubMed ID: 21809030
    [Abstract] [Full Text] [Related]

  • 11. Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carcinoma.
    Chen YJ, Chi CW, Su WC, Huang HL.
    Oncotarget; 2014 Jul 15; 5(13):4845-54. PubMed ID: 24947784
    [Abstract] [Full Text] [Related]

  • 12. EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
    Luo X, Xie H, Long X, Zhou M, Xu Z, Shi B, Jiang H, Li Z.
    PLoS One; 2013 Jul 15; 8(12):e83332. PubMed ID: 24376686
    [Abstract] [Full Text] [Related]

  • 13. Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.
    Wang M, Huang C, Su Y, Yang C, Xia Q, Xu DJ.
    J Pharm Pharmacol; 2017 Jun 15; 69(6):743-752. PubMed ID: 28266023
    [Abstract] [Full Text] [Related]

  • 14. Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway.
    Kuang M, Cen Y, Qin R, Shang S, Zhai Z, Liu C, Pan X, Zhou H.
    Cell Physiol Biochem; 2018 Jun 15; 47(2):475-488. PubMed ID: 29794440
    [Abstract] [Full Text] [Related]

  • 15. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.
    Xu W, Bi Y, Kong J, Zhang J, Wang B, Li K, Tian M, Pan X, Shi B, Gu J, Jiang H, Kong X, Li Z.
    Oncotarget; 2016 Apr 26; 7(17):24752-65. PubMed ID: 27029073
    [Abstract] [Full Text] [Related]

  • 16. Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.
    Li YY, Lam SK, Mak JC, Zheng CY, Ho JC.
    Lung Cancer; 2013 Sep 26; 81(3):354-361. PubMed ID: 23769318
    [Abstract] [Full Text] [Related]

  • 17. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
    Wu JY, Wang ZX, Zhang G, Lu X, Qiang GH, Hu W, Ji AL, Wu JH, Jiang CP.
    Int J Nanomedicine; 2018 Sep 26; 13():1265-1280. PubMed ID: 29551896
    [Abstract] [Full Text] [Related]

  • 18. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, Nurdinov N, Ozpolat B.
    Anticancer Agents Med Chem; 2021 Sep 26; 21(3):355-364. PubMed ID: 32767958
    [Abstract] [Full Text] [Related]

  • 19. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.
    Ou Y, He J, Liu Y.
    IUBMB Life; 2018 Jun 26; 70(6):468-478. PubMed ID: 29676845
    [Abstract] [Full Text] [Related]

  • 20. Radiation induces autophagic cell death via the p53/DRAM signaling pathway in breast cancer cells.
    Cui L, Song Z, Liang B, Jia L, Ma S, Liu X.
    Oncol Rep; 2016 Jun 26; 35(6):3639-47. PubMed ID: 27109777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.